TARDBP and amyotrophic lateral sclerosis: Loss of this nuclear retention mechanism could be one factor that contributes to TDP-43 mislocalization and disease progression in ALS/FTD, possibly as a consequence of the widespread RNA processing changes that occur in both diseases3.